Coronary Stents Market Size, Share, and Trends 2025 to 2034

Coronary Stents Market (By Product Type: Drug-Eluting Stents (DES), Bare-Metal Stents (BMS), Bioresorbable Vascular Scaffolds (BVS) / Bioresorbable Stents, Covered Stents, Others; By Biomaterials: Metallic Biomaterials, Polymeric Biomaterials, Natural Biomaterials; By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Cardiac Centers, Others (e.g., Catheterization Labs); By Type of Expansion: Balloon-Expandable Stents, Self-Expandable Stents; By Application: Coronary Artery Disease, Peripheral Artery Disease)) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034

Last Updated : November 2025  |  Report Code : 1932  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Coronary Stents Market 

5.1. COVID-19 Landscape: Coronary Stents Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Coronary Stents Market, By Product Type

8.1. Coronary Stents Market, by Product Type

8.1.1. Drug-Eluting Stents (DES)

8.1.1.1. Market Revenue and Forecast

8.1.2. Bare-Metal Stents (BMS)

8.1.2.1. Market Revenue and Forecast

8.1.3. Bioresorbable Vascular Scaffolds (BVS) / Bioresorbable Stents

8.1.3.1. Market Revenue and Forecast

8.1.4. Covered Stents

8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Coronary Stents Market, By Biomaterials

9.1. Coronary Stents Market, by Biomaterials

9.1.1. Metallic Biomaterials

9.1.1.1. Market Revenue and Forecast

9.1.2. Polymeric Biomaterials

9.1.2.1. Market Revenue and Forecast

9.1.3. Natural Biomaterials

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global Coronary Stents Market, By End-User 

10.1. Coronary Stents Market, by End-User

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast

10.1.2. Ambulatory Surgical Centers (ASCs)

10.1.2.1. Market Revenue and Forecast

10.1.3. Cardiac Centers

10.1.3.1. Market Revenue and Forecast

10.1.4. Others (e.g., Catheterization Labs)

10.1.4.1. Market Revenue and Forecast

Chapter 11. Global Coronary Stents Market, By Type of Expansion

11.1. Coronary Stents Market, by Type of Expansion

11.1.1. Balloon-Expandable Stents

11.1.1.1. Market Revenue and Forecast

11.1.2. Self-Expandable Stents

11.1.2.1. Market Revenue and Forecast

Chapter 12. Global Coronary Stents Market, By Application

12.1. Coronary Stents Market, by Application

12.1.1. Coronary Artery Disease

12.1.1.1. Market Revenue and Forecast

12.1.2. Peripheral Artery Disease

12.1.2.1. Market Revenue and Forecast

Chapter 13. Global Coronary Stents Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product Type

13.1.2. Market Revenue and Forecast, by Biomaterials

13.1.3. Market Revenue and Forecast, by End-User

13.1.4. Market Revenue and Forecast, by Type of Expansion

13.1.5. Market Revenue and Forecast, by Application

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product Type

13.1.6.2. Market Revenue and Forecast, by Biomaterials

13.1.6.3. Market Revenue and Forecast, by End-User

13.1.6.4. Market Revenue and Forecast, by Type of Expansion

13.1.6.5. Market Revenue and Forecast, by Application  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product Type

13.1.7.2. Market Revenue and Forecast, by Biomaterials

13.1.7.3. Market Revenue and Forecast, by End-User

13.1.7.4. Market Revenue and Forecast, by Type of Expansion

13.1.7.5. Market Revenue and Forecast, by Application

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product Type

13.2.2. Market Revenue and Forecast, by Biomaterials

13.2.3. Market Revenue and Forecast, by End-User

13.2.4. Market Revenue and Forecast, by Type of Expansion  

13.2.5. Market Revenue and Forecast, by Application  

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product Type

13.2.6.2. Market Revenue and Forecast, by Biomaterials

13.2.6.3. Market Revenue and Forecast, by End-User

13.2.7. Market Revenue and Forecast, by Type of Expansion  

13.2.8. Market Revenue and Forecast, by Application  

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product Type

13.2.9.2. Market Revenue and Forecast, by Biomaterials

13.2.9.3. Market Revenue and Forecast, by End-User

13.2.10. Market Revenue and Forecast, by Type of Expansion

13.2.11. Market Revenue and Forecast, by Application

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product Type

13.2.12.2. Market Revenue and Forecast, by Biomaterials

13.2.12.3. Market Revenue and Forecast, by End-User

13.2.12.4. Market Revenue and Forecast, by Type of Expansion

13.2.13. Market Revenue and Forecast, by Application

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product Type

13.2.14.2. Market Revenue and Forecast, by Biomaterials

13.2.14.3. Market Revenue and Forecast, by End-User

13.2.14.4. Market Revenue and Forecast, by Type of Expansion

13.2.15. Market Revenue and Forecast, by Application

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product Type

13.3.2. Market Revenue and Forecast, by Biomaterials

13.3.3. Market Revenue and Forecast, by End-User

13.3.4. Market Revenue and Forecast, by Type of Expansion

13.3.5. Market Revenue and Forecast, by Application

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product Type

13.3.6.2. Market Revenue and Forecast, by Biomaterials

13.3.6.3. Market Revenue and Forecast, by End-User

13.3.6.4. Market Revenue and Forecast, by Type of Expansion

13.3.7. Market Revenue and Forecast, by Application

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product Type

13.3.8.2. Market Revenue and Forecast, by Biomaterials

13.3.8.3. Market Revenue and Forecast, by End-User

13.3.8.4. Market Revenue and Forecast, by Type of Expansion

13.3.9. Market Revenue and Forecast, by Application

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product Type

13.3.10.2. Market Revenue and Forecast, by Biomaterials

13.3.10.3. Market Revenue and Forecast, by End-User

13.3.10.4. Market Revenue and Forecast, by Type of Expansion

13.3.10.5. Market Revenue and Forecast, by Application

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product Type

13.3.11.2. Market Revenue and Forecast, by Biomaterials

13.3.11.3. Market Revenue and Forecast, by End-User

13.3.11.4. Market Revenue and Forecast, by Type of Expansion

13.3.11.5. Market Revenue and Forecast, by Application

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product Type

13.4.2. Market Revenue and Forecast, by Biomaterials

13.4.3. Market Revenue and Forecast, by End-User

13.4.4. Market Revenue and Forecast, by Type of Expansion

13.4.5. Market Revenue and Forecast, by Application

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product Type

13.4.6.2. Market Revenue and Forecast, by Biomaterials

13.4.6.3. Market Revenue and Forecast, by End-User

13.4.6.4. Market Revenue and Forecast, by Type of Expansion

13.4.7. Market Revenue and Forecast, by Application

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product Type

13.4.8.2. Market Revenue and Forecast, by Biomaterials

13.4.8.3. Market Revenue and Forecast, by End-User

13.4.8.4. Market Revenue and Forecast, by Type of Expansion

13.4.9. Market Revenue and Forecast, by Application

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product Type

13.4.10.2. Market Revenue and Forecast, by Biomaterials

13.4.10.3. Market Revenue and Forecast, by End-User

13.4.10.4. Market Revenue and Forecast, by Type of Expansion

13.4.10.5. Market Revenue and Forecast, by Application

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product Type

13.4.11.2. Market Revenue and Forecast, by Biomaterials

13.4.11.3. Market Revenue and Forecast, by End-User

13.4.11.4. Market Revenue and Forecast, by Type of Expansion

13.4.11.5. Market Revenue and Forecast, by Application

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product Type

13.5.2. Market Revenue and Forecast, by Biomaterials

13.5.3. Market Revenue and Forecast, by End-User

13.5.4. Market Revenue and Forecast, by Type of Expansion

13.5.5. Market Revenue and Forecast, by Application

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product Type

13.5.6.2. Market Revenue and Forecast, by Biomaterials

13.5.6.3. Market Revenue and Forecast, by End-User

13.5.6.4. Market Revenue and Forecast, by Type of Expansion

13.5.7. Market Revenue and Forecast, by Application

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product Type

13.5.8.2. Market Revenue and Forecast, by Biomaterials

13.5.8.3. Market Revenue and Forecast, by End-User

13.5.8.4. Market Revenue and Forecast, by Type of Expansion

13.5.8.5. Market Revenue and Forecast, by Application

Chapter 14. Company Profiles

14.1. Medtronic plc

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Cook Medical

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. B. Braun Melsungen AG

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Terumo Corporation

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Vascular Concepts

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. STENTYS SA

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. MicroPort Scientific Corporation

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Meril Life Sciences Pvt. Ltd

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Translumina

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Biosensors International Group Limited

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global coronary stents market size was reached at USD 10.35 billion in 2025 and is projected to hit around USD 17.40 billion by 2034.

The global coronary stents market is growing at a CAGR of 6% from 2025 to 2034.

The prominent players operating in the coronary stents market are Medtronic plc, Cook Medical, B. Braun Melsungen AG, Terumo Corporation, Vascular Concepts, STENTYS SA, MicroPort Scientific Corporation, and Meril Life Sciences Pvt. Ltd.

Increased cases of obesity and diabetes due to sedentary lifestyles and availability of good infrastructure and insurance policies are expected to drive coronary stents market.

North America region will lead the global coronary stents market in the upcoming years.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client